{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T06:06:09Z","timestamp":1781676369387,"version":"3.54.5"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","publichealthjrnl.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Public Health"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.puhe.2015.03.006","type":"journal-article","created":{"date-parts":[[2015,4,28]],"date-time":"2015-04-28T04:47:03Z","timestamp":1430196423000},"page":"783-789","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Treatment outcome and its attributes in TB-HIV co-infected patients registered under Revised National TB Control Program: a retrospective cohort analysis"],"prefix":"10.1016","volume":"129","author":[{"given":"N.N.","family":"Ambadekar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.P.","family":"Zodpey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.N.","family":"Soni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.P.","family":"Lanjewar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.puhe.2015.03.006_bib1","series-title":"Global tuberculosis report \u2013 2012","author":"World Health Organisation","year":"2012"},{"key":"10.1016\/j.puhe.2015.03.006_bib2","series-title":"National AIDS Control Organisation","author":"National Institute of Medical Statistics","year":"2010"},{"key":"10.1016\/j.puhe.2015.03.006_bib3","series-title":"National AIDS control program phase III: state fact sheets","author":"National AIDS Control Organisation","year":"2012"},{"key":"10.1016\/j.puhe.2015.03.006_bib4","series-title":"National framework for joint TB\/HIV collaborative activities","author":"National AIDS Control Organisation and Central TB Division","year":"2009"},{"issue":"2","key":"10.1016\/j.puhe.2015.03.006_bib5","first-page":"247","article-title":"National estimate of HIV seroprevalence among tuberculosis patients in India","volume":"14","author":"Dewan","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.puhe.2015.03.006_bib6","series-title":"Technical report, India HIV estimates-2006: ICMR","author":"National AIDS Control Organization & National Institute of Medical Statistic I","year":"2006"},{"key":"10.1016\/j.puhe.2015.03.006_bib7","series-title":"Treatment of tuberculosis: guidelines for national treatment programmes","author":"WHO","year":"2004"},{"issue":"1","key":"10.1016\/j.puhe.2015.03.006_bib8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1086\/375220","article-title":"Effects of human immunodeficiency virus infection on recurrence of tuberculosis after rifampin-based treatment: an analytical review","volume":"37","author":"Korenromp","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.puhe.2015.03.006_bib9","first-page":"455","article-title":"The impact of HIV infection on recurrence of tuberculosis in South African gold miners","volume":"4","author":"Mallory","year":"2000","journal-title":"Int J Tuberc Lung Dis"},{"issue":"4","key":"10.1016\/j.puhe.2015.03.006_bib10","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1183\/09031936.05.10090404","article-title":"Should tuberculosis treatment and control be addressed differently in HIV-infected and -uninfected individuals?","volume":"25","author":"Dlodlo","year":"2005","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.puhe.2015.03.006_bib11","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1086\/318706","article-title":"A review of efficacy studies of 6-month short-course therapy for tuberculosis among patients infected with human immunodeficiency virus: differences in study outcomes","volume":"32","author":"El-Sadr","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.puhe.2015.03.006_bib12","first-page":"616","article-title":"Preventing recurrent tuberculosis in high HIV-prevalent areas in Sub-Saharan Africa: what are the options for tuberculosis control programmes?","volume":"7","author":"Harries","year":"2003","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.puhe.2015.03.006_bib13","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1086\/430377","article-title":"Judith sackoff relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997\u20132000","volume":"41","author":"Li","year":"2005","journal-title":"CID"},{"key":"10.1016\/j.puhe.2015.03.006_bib14","unstructured":"Revised National Tuberculosis Control Program. Training course for program manager (Module 1\u20134). Central TB Division, Directorate General of Health services, Ministry of Health and Family Welfare: Nirman Bhavan, New Delhi, 110011."},{"key":"10.1016\/j.puhe.2015.03.006_bib15","series-title":"National framework for joint TB\/HIV collaborative activities","first-page":"1","year":"2007"},{"key":"10.1016\/j.puhe.2015.03.006_bib16","series-title":"RNTCP performance report, India: first quarter","year":"2011"},{"key":"10.1016\/j.puhe.2015.03.006_bib17","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1164\/rccm.200509-1529OC","article-title":"Treatment outcomes of patients with HIV and tuberculosis","volume":"175","author":"Nahid","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.puhe.2015.03.006_bib18","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1086\/651686","article-title":"Treatment of active tuberculosis in HIV-coinfected patients: a systematic review and meta-analysis","volume":"50","author":"Khan","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.puhe.2015.03.006_bib19","first-page":"636","article-title":"Global epidemiology of childhood tuberculosis","volume":"8","author":"Nelson","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"issue":"6","key":"10.1016\/j.puhe.2015.03.006_bib20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0014-2565(03)71266-1","article-title":"Recurrent tuberculosis in patients with coinfection by HIV","volume":"203","author":"Garc\u00eda Ord\u00f3\u00f1ez","year":"2003","journal-title":"Rev Clin Esp"},{"issue":"6","key":"10.1016\/j.puhe.2015.03.006_bib21","doi-asserted-by":"crossref","first-page":"e507","DOI":"10.1371\/journal.pone.0000507","article-title":"HIV-associated TB in an Giang Province, Vietnam, 2001\u20132004: epidemiology and TB treatment outcomes","author":"Thuy","year":"2007","journal-title":"PLoS ONE"},{"key":"10.1016\/j.puhe.2015.03.006_bib22","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1097\/00002030-199908200-00015","article-title":"Relapse and mortality among HIV-infected and uninfected patients with tuberculosis successfully treated with twice weekly directly observed therapy in rural South Africa","volume":"13","author":"Connolly","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.puhe.2015.03.006_bib23","first-page":"829","article-title":"Long-term outcome in patients registered with tuberculosis in Zomba, Malawi: mortality at 7 years according to initial HIV status and type of TB","volume":"8","author":"Kang'ombe","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.puhe.2015.03.006_bib24","unstructured":"Mwaungulu FB, Floyd S, Crampin AC, Kasimba S, Malema S. Cotrimoxazole prophylaxis reduces mortality in human immunodeficiency virus-positive tuberculosis patients in Karonga District, Malawi. Bull WHO 82:854\u201363."},{"key":"10.1016\/j.puhe.2015.03.006_bib25","doi-asserted-by":"crossref","unstructured":"Boeree MJ, Sauvageot D, Banda HT, Harries AD, Zijlstra EE. Efficacy and safety of two dosages of cotrimoxazole as preventive treatment for HIV infected Malawian adults with new smear-positive tuberculosis. Trop Med Int Health 10:723\u201333.","DOI":"10.1111\/j.1365-3156.2005.01433.x"},{"key":"10.1016\/j.puhe.2015.03.006_bib26","doi-asserted-by":"crossref","unstructured":"Grimwade K, Sturm AW, Nunn AJ, Mbatha D, Zungu D, Gilks CF. Effectiveness of cotrimoxazole prophylaxis on mortality in adults with tuberculosis in rural South Africa. AIDS 19:163\u20138.","DOI":"10.1097\/00002030-200501280-00008"},{"key":"10.1016\/j.puhe.2015.03.006_bib27","series-title":"The Cochrane Library, issue 2","article-title":"Cotrimoxazole prophylaxis for opportunistic infections in adults with HIV (Cochrane Review)","author":"Grimwade","year":"2004"},{"key":"10.1016\/j.puhe.2015.03.006_bib28","series-title":"Guidelines on co-trimoxazole prophylaxis for HIV-related infections among children, adolescents and adults: recommendations for a public health approach","author":"World Health Organisation","year":"2006"},{"issue":"6","key":"10.1016\/j.puhe.2015.03.006_bib29","doi-asserted-by":"crossref","first-page":"e5999","DOI":"10.1371\/journal.pone.0005999","article-title":"Linking HIV-infected TB patients to cotrimoxazole prophylaxis and antiretroviral treatment in India","volume":"4","author":"Raizada","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.puhe.2015.03.006_bib30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1258\/004947506776593387","article-title":"Antiretroviral therapy and TB","volume":"36","author":"Swaminathan","year":"2006","journal-title":"Trop Dr"},{"key":"10.1016\/j.puhe.2015.03.006_bib31","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3201\/eid1307.061506","article-title":"Antiretroviral therapy during tuberculosis treatment and marked reduction in death rate of HIV-infected patients","volume":"13","author":"Akksilp","year":"2007","journal-title":"Thail Emerg Infect Dis"},{"key":"10.1016\/j.puhe.2015.03.006_bib32","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/QAI.0b013e318177594e","article-title":"Antiretroviral therapy for HIV-infected tuberculosis patients saves lives but needs to be used more frequently in Thailand","volume":"48","author":"Sanguanwongse","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.puhe.2015.03.006_bib33","series-title":"Standards for TB care in India","author":"World Health Organisation","year":"2014"}],"container-title":["Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033350615001213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033350615001213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,23]],"date-time":"2018-09-23T02:52:10Z","timestamp":1537671130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033350615001213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0033350615001213"],"URL":"https:\/\/doi.org\/10.1016\/j.puhe.2015.03.006","relation":{},"ISSN":["0033-3506"],"issn-type":[{"value":"0033-3506","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment outcome and its attributes in TB-HIV co-infected patients registered under Revised National TB Control Program: a retrospective cohort analysis","name":"articletitle","label":"Article Title"},{"value":"Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.puhe.2015.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}